What hepatitis B screening actually measures
Screening for hepatitis B is a laboratory question about your immune status and whether the virus is present. The tests are not interchangeable, and a single result rarely answers the whole question.
Hepatitis B surface antigen (HBsAg) is the main marker of current infection. If it is positive, the person is generally considered infected and potentially able to pass the virus to others, although a clinician confirms this. Hepatitis B surface antibody (anti-HBs) indicates immunity, either from vaccination or from past infection that has cleared. Hepatitis B core antibody (anti-HBc) shows that a person has been exposed to the virus at some point; the IgM form suggests recent infection, while total or IgG core antibody suggests past exposure.
When HBsAg is positive, clinicians usually look further. Hepatitis B e antigen (HBeAg) and its antibody help describe the phase of infection. HBV DNA measures how much viral genetic material is in the blood. Liver enzyme tests such as ALT and AST show whether the liver is inflamed, and additional tests may assess liver stiffness or scarring.
The practical point for an overseas patient is that 'hepatitis B screening' can mean different panels in different settings. A pre-vaccination check, a blood-donor screen, a pre-operative requirement and a full assessment of known infection are not the same request. Ask which markers the proposed panel includes before you treat a result as complete.
Reading a result pattern rather than one line
Laboratory reports list each marker separately, and patients often focus on whichever line is flagged. The useful interpretation comes from the combination.
A positive surface antibody with negative surface antigen and negative core antibody is a pattern consistent with vaccination-derived immunity. A positive surface antigen means current infection and calls for clinical assessment, not just a repeat test. Positive core antibody with negative surface antigen can indicate past infection, and in some situations clinicians will check HBV DNA to clarify whether virus is still present. Isolated core antibody positivity can also have other explanations, which is why the treating clinician reviews the whole picture.
Results near a laboratory's cutoff, results from different laboratories, and results taken shortly after vaccination or exposure can all need context. Do not assume a positive or negative line means the same thing in every panel.
This is also where records matter. If you already have hepatitis B results from your home country, the Chinese clinician needs the actual report with the marker names, values, units and reference ranges, not a summary such as 'hepatitis B positive'. A report in another language may need translation, and the receiving hospital can say what it accepts. Ask whether the clinician wants the original laboratory printout or a translated copy, and whether any prior test needs repeating in China.
When screening becomes an assessment of known infection
If you already know you have chronic hepatitis B, the question changes from 'do I have it' to 'how is it affecting my liver and what monitoring or treatment do I need'. That assessment is a clinical process, and it belongs to a hepatologist or gastroenterologist rather than to a screening package.
A clinician will usually want to understand your history: when infection was found, whether you have had flares, what treatment you have taken, and whether there is any family history of liver disease or liver cancer. They will review liver function tests, HBV DNA, and markers of liver fibrosis or scarring. Imaging may be part of the assessment. Which tests are needed, and how often, is an individual decision.
This is also the point to raise medication questions. Hepatitis B treatment decisions depend on viral activity, liver injury, age, pregnancy plans and other health conditions. Do not stop, start or change antiviral medication because of an article or because you are travelling. Ask the treating clinician how your current prescription should be continued and what monitoring is appropriate.
Pregnancy deserves separate mention. Screening in pregnancy has implications for the baby's preventive care, and the timing and interpretation of tests are matters for the obstetric and hepatitis teams. If you are pregnant or planning pregnancy, say so at the first contact so the right clinicians are involved.
What to prepare before you travel for screening
Preparation is mostly about records and clarity of purpose. You do not need to send a complete medical archive at first contact; a short summary is enough to start.
Bring the laboratory reports that already exist, including dates, marker names, values and units. If you have had imaging of the liver, bring the reports and, where possible, the images themselves. A list of your current medicines, including antivirals and any supplements, helps the clinician understand your situation. If you have been vaccinated against hepatitis B, the vaccination record is useful because it helps explain antibody results.
Be clear about why you want screening. A routine check, a requirement before a procedure, a pregnancy-related check and follow-up of known infection lead to different conversations. The hospital decides which tests are appropriate; a screening package is not a substitute for a specialist assessment of symptoms or known disease.
If you have current symptoms such as jaundice, dark urine, severe fatigue, abdominal swelling or confusion, do not plan around travel. Seek urgent local medical care first. Screening is for people without an acute problem, and worsening symptoms take priority over any overseas appointment.
Practical arrangements and where responsibility sits
Our role is information and non-clinical coordination. We can help you identify the right type of specialist, prepare a short summary of your question, and discuss appointment registration and interpretation support. We do not diagnose, interpret your results or decide whether you need treatment; those decisions belong to the treating hospital and licensed clinicians.
For a routine preventive checkup, our health checkup planning page explains how base packages and add-ons work and why a clinician should advise which tests are suitable. For known liver disease, the chronic liver disease care page describes the specialist route. Hospital consultation fees, tests and treatment are paid to the hospital or provider, and our coordination fees are separate. An initial enquiry is free and does not require buying a proxy consultation.
Questions to ask the receiving clinician
The answers depend on your history and the hospital's own practice, so ask rather than assume. Which markers does the proposed panel include, and will HBV DNA and liver function tests be part of it? Does the clinician want my existing reports translated, or will the hospital repeat selected tests? If I have chronic hepatitis B, what monitoring or treatment review will be arranged, and who will manage my prescription during the visit? What does the written quote cover, and which charges are paid separately to the hospital?
These questions turn a vague plan into something you can check. They also make clear where responsibility sits: the hospital assesses suitability and the clinician interprets results. Our team can help you put the questions in writing and coordinate the practical arrangements around the appointment.
A practical next step
Start with a short summary: your main question, whether you have known hepatitis B or only want a routine check, the dates of your existing reports and any current medicines. Send it through the enquiry form, email or WhatsApp, and we will explain what information is missing and which next step fits. If you have symptoms that are worsening, contact a local clinician first rather than waiting for an overseas plan.
Sources & scope of this guide
References and official service information relevant to this guide.
- health checkup
- Chronic liver disease care
- WHO: Hepatitis B
- CDC: Hepatitis B Clinical Testing and Diagnosis
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
